๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Growth inhibition and protein tyrosine phosphorylation in MCF 7 breast cancer cells by a novel K vitamin

โœ Scribed by Siddhartha Kar; Brian I. Carr


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
213 KB
Volume
185
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Lack of modulation of MDR1 gene expressi
โœ Amadeo M. Parissenti; Brian R. Gannon; David J. Villeneuve; Angela F. Kirwan-rhu ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 172 KB ๐Ÿ‘ 1 views

The drug transporter P-glycoprotein (P-gp) appears to play an important role in the ability of tumor cells to evade killing by chemotherapeutic agents. Using pharmacological inhibitors of cAMP-dependent protein kinase (PKA), it has been suggested that, similar to rodent model systems, the human P-gp

Involvement of hepatocyte epidermal grow
โœ Ziqiu Wang; Meifang Wang; Brian I. Carr ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 173 KB ๐Ÿ‘ 2 views

Compound 5 (Cpd 5), a synthetic K vitamin analogue, or 2-(2-mercaptoethanol)-3-methyl-1,4-naphthoquinone, is a potent inhibitor of epidermal growth factor (EGF)-induced rat hepatocyte DNA synthesis and induces EGF receptor (EGFR) tyrosine phosphorylation. To understand the cellular responses to Cpd